Cronos Confirms That It Has Received Expressions Of Interest, While Curaleaf Refuses To Comment

Cronos Group (TSX: CRON) has confirmed that it has received what amounts to “a number” of unsolicited indications of interest for the potential sale of the company.

The indications of interest are said to come from third parties, with each involving a potential transaction. Cronos however has not provided details on who is seemingly interested in acquiring the company, instead electing to state that it is in the early stages of reviewing each offer, and that there can be no assurance that anything comes of the discussions.

The announcement follows a rumor that was leaked and reported on by Reuters, who suggested that the Canadian cannabis operator was in discussions to be acquired by Curaleaf Holdings (CSE: CURA), a US-based multi-state operator.

Curaleaf for its part at the request of IIROC this morning commented on the media reports, just to say that the company’s policy is “to refrain from commenting on market rumors.”

Altamira Gold Corp. — sponsored Sponsored · Altamira Gold Corp.

The confirmation of third party expressions of interest being received by Cronos all but confirms that the “leak” was conducted in an attempt to get a higher figure in a potential sale. That strategy however has appeared to fail spectacularly, with Cronos closing down 3%, after initially jumping over 19%.


Information for this briefing was found via Sedar, Reuters and the sources mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Building the $500M-a-Year Gold Mine | Victor Cantore – Amex Gold Mining

Building the Next 500,000-Ounce Gold Producer | Stephen Soock – Heliostar Metals

This Gold Explorer Is Making Its Biggest Bet | Brian Miller – Astra Exploration

Recommended

This Gold Discovery Just Keeps Getting Bigger | Roger Rosmus – Goliath Resources

Cardiol Expands MAVERIC Trial to Up to 150 Patients After Reaching Enrollment Target Early

Related News

Curaleaf To Acquire Reef Dispensaries For US$286 Million

It may have been delayed by two years, but it appears that Tryke Companies, whom...

Monday, November 8, 2021, 07:49:53 AM

Curaleaf Holdings Borrows $50 Million At 10.25% Via Secured Credit Facility

Evidently Curaleaf Holdings (CSE: CURA) was not fully satisfied with its recent C$275.6 million financing...

Monday, January 11, 2021, 09:04:53 AM

Curaleaf: Canccord Slashes Price Target, Anticipates Headwinds For 2022

Earlier this month, Curaleaf Holdings, Inc. (CSE: CURA reported its fourth quarter and full year...

Monday, March 14, 2022, 09:27:00 AM

Cronos Group Posts Revenues Of $12.6 Million, Net Loss Of $161.6 Million

Cronos Group (TSX: CRON) (NASDAQ: CRON) this morning reported its first quarter financial results, leaving...

Friday, May 7, 2021, 08:18:02 AM

US Cannabis: Illustrating The Performance Of The Top Four Issuers

The upcoming US election has renewed interest in CSE-listed American cannabis operators, many of which...

Monday, October 26, 2020, 12:30:00 PM